X-Ra was associated with moderate but highly significant and consistent reductions of XIST expression 38 , 20q ( RTEL1 ), and 8q ( MYC ) copy number gains 21 ; 8p ( CSMD1 ) deletions 26 ; lower breast cancer survival 39 and basal type 1 TNBC 27 .
1
—
—